Skip to main content

Axon and Affymetrix to Co-Develop Next-Generation GeneChip Scanner

NEW YORK, March 19 - Just two months after Affymetrix rolled out its own GeneChip 3000 scanner, Axon instruments announced that the two companies will be co-developing a scanner that will handle future versions of Affymetrix GeneChip-brand microarrays.


Axon, of Union City, Calif.and Melbourne, Australia, will modify its ImageExpress high-throughput cellular screening system - a high-end instrument - for screening of the arrays, the company said. 


The instrument will be designed to scan arrays that are formatted in microwell plates, which Affymetrix said recently it was developing for large-scale testing and diagnostic applications. (See BioArray News article.)


Axon also said it has already delivered three customized ImageExpress instruments to Affymetrix, but did not disclose the financial terms of the agreement.


Affymetrix launched its own GeneChip 3000 instrument in January, just as an earlier agreement with competitor Agilent technologies, under which Agilent produced a scanner for Affymetrix, was set to expire.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.